ISSN: 2692-4749
Open Journal of Tropical Medicine
Short communication       Open Access      Peer-Reviewed

Attention to the problem of the inaccurate testing caused by virus mutation strains in clinical laboratory settings

Gao Yulu*

Department of Laboratory Medicine, Kunshan Hospital Affiliated to Nanjing University of Traditional Chinese Medicine, Kunshan 215300, Jiangsu Province, China
*Corresponding author: Gao Yulu, Department of Laboratory Medicine, Kunshan Hospital Affiliated to Nanjing University of Traditional Chinese Medicine, Kunshan 215300, Jiangsu Province, China; E-mail:
Received: 04 January, 2017 | Accepted: 08 February, 2017 | Published: 09 February, 2017

Cite this as

Yulu G (2017) Attention to the problem of the inaccurate testing caused by virus mutation strains in clinical laboratory settings. Glob J Clin Virol 2(1): 001-002. DOI: 10.17352/gjcv.000003


A few virus strain mutations for many viruses can cause the problem of the inaccurate testing in clinical laboratory settings. Therefore, we put forward the following strategies and recommendations including re-examination using different methods or a comparative study or a parallel control study by different kits, and performing virus nucleic acid sequencing analysis if necessary.

In recent years, in vitro diagnostic test for the virus has made significant progress [1]. From a methodological point of view, these diagnostic tools were more and more accurate and reliable, but there are still some problems that should be paid attention to, especially for the problem of the inaccurate testing caused by virus strain mutation in clinical laboratory settings.

At present, the most common methods of virus testing in clinical laboratory settings include as following: serological diagnosis based on antigen or antibody such as ELISA [2-4], and nucleic acid test methods including PCR [5], RT-PCR [6, 7], real-time PCR [8-13], and molecular hybridization [14-16], etc. However, there may be different test results when different kits or test methods were used.

In theory, many viruses such as human papillomavirus (HPV) [15], hepatitis B virus (HBV) [17], hepatitis C virus HCV [18] and herpes simplex virus (HSV) [19] have many genotypes and nucleic acid polymorphisms, resulting in immunological diversity of immune antigen or antibody, and a few mutated proteins cannot be combined with antigen or antibody of diagnostic reagents and lead to a failure in testing. As has been recently reported that: there occurred inconsistent detection results of HBV for 30 blood donors among two ELISA reagents and HBV quantitative real-time PCR detection kit [19]. The further research showed that the mutations of S gene in HBV resulted in inaccurate results [20].

However, virus nucleic acid polymorphisms can cause a difficulty in design of PCR primers and probes. Imperfect primer design would decrease amplification efficiency. In fact, for many viruses, due to nucleic acid variability, the matched primers covering all viruses cannot be achieved. For example, the reported primers and probe designed with S gene target gene of HBV sequence in a HBV fluorescent quantitative PCR kit widely used in clinical settings of China are as following:




But according to the reported primers and probe, we conducted the similarity alignment of DNA sequence in Genebank and found that their bases cannot strictly match with DNA sequence in few HBV strains. Similarly, HPV has too great nucleic acid variability to design perfect primers and probe in theory, suggesting that vitro diagnostic kits had some defects due to the low efficiency amplification even false negative results caused by the problem of primers. Similarly, mutations in viral nucleic acids can lead to peptide mutations in the antigen or antibody, resulting in incorrect diagnostic results, which affects the accuracy of immune diagnostic kits in vitro. Thus, the following strategies and recommendations are putted forward: i) when being clinical diagnosed as viral infection and highly suspected test results, re-examination should be performed in other ways or diagnostic tools; ii) for some extremely important diagnostic experiments in vitro, there must rely on different methods to improve the sensitivity and accuracy of diagnosis. For example, HBV diagnostic assay for blood donor is vital to blood safety, and thereby the tests should use two different reagents. HBV ELISA and nucleic acid testing are recommended as reliable tools, which can significantly reduce the spread of occult HBV infection and improve blood transfusion security; iii) pays more attention to the diagnostic performance analysis for clinically diagnostic reagents and conducts a comparative study or a parallel control study using different kits; and iv) investigates the reasons for incorrect experimental results, and conducts virus nucleic acid sequencing analysis if necessary.

  1. Murphy MP (2012) Progress report: why we still don't have a reliable gold standard for in vitro diagnostic genetic testing. MLO Med Lab Obs  44 : 36- 38. Link:
  2. Bystryak S, Acharya C (2016) Detection of HIV-1 p24 antigen in patients with varying degrees of viremia using an ELISA with a photochemical signal amplification system. Clin Chim Acta   456: 128-136. Link:
  3. Gutlapalli R, Sykam A, Tenali SP, Chandran P, Suneetha S, et al. (2016) Detection of Tuberculosis in HIV Co-infected Individuals: Use of Multiple ELISA Responses to 38kDa, Lipoarabinomannan and ESAT- 6 of M. tuberculosis: J Clin Diagn Res  JCDR, 10: KC01-04. Link:
  4. Li J, Cheng B, Yang L, Zhao Y, Pan M, Zheng G, Xu X, et al. (2016) Development and Implementation of Autoverification Rules for ELISA Results of HBV Serological Markers: J Lab Autom  21: 642-651. Link:
  5. Prakash P, Patne SC, Singh AK, Kumar M, Mishra MN (2016)  Gulati AK: PCR and Genotyping for HPV in Cervical Cancer Patients. J Glob Infect Dis 8: 100-107. Link:
  6. Zhang EZ, Bartels DJ, Frantz JD, Seepersaud S, Lippke JA, et al. (2013) Development of a sensitive RT-PCR method for amplifying and sequencing near full-length HCV genotype 1 RNA from patient samples : Virol J  10:  53. Link:
  7. Guichet E, Aghokeng A, Eymard-Duvernay S, Vidal N, Ayouba A, et al. (2016) Field evaluation of an open and polyvalent universal HIV-1/SIVcpz/SIVgor quantitative RT-PCR assay for HIV-1 viral load monitoring in comparison to Abbott RealTime HIV-1 in Cameroon: J Virol Methods  237: 121-126. Link:
  8. Park S, Wang HY, Kim S, Kim G, Lee D, et al. (2016)  Combination of HPV E6/E7 and HTERT mRNA real-time RT-PCR assay for diagnosing high grade cervical lesions and malignancy: Pathology 48 Suppl 1: S149. Link:
  9. Paryan M, Khodayar M, Kia V, Mohammadi-Yeganeh S, Kaghazian H(2016)  Development of an in-House TaqMan Real-Time PCR-Based Method to Detect Residual Host Cell DNA in HBV Vaccine: Appl Biochem Biotechnol 179 : 375-382. Link:
  10. Sohrabi A, Rahnamaye-Farzami M, Mirab-Samiee S, Mahdavi S, Babaei M (2016) Comparison of In-House Multiplex Real Time PCR, Diagcor GenoFlow HPV Array Test and INNO-LiPA HPV Genotyping Extra Assays with LCD- Array Kit for Human Papillomavirus Genotyping in Cervical Liquid Based Cytology Specimens and Genital Lesions in Tehran, Iran: Clin Lab 62 : 615-619. Link:
  11. Wongjitrat C, Horthongkham N, Sutthent R, Srisurapanon S (2015) Comparison of Droplet Digital PCR and Real Time PCR Method for HBV DNA Quantification: Journal of the Medical Association of Thailand = Chotmaihet thangphaet  98 Suppl 9: S140-145. Link:
  12. Zhou L, Gong R, Lu X, Zhang Y, Tang J (2015) Development of a Multiplex Real-Time PCR Assay for the Detection of Treponema pallidum, HCV, HIV-1, and HBV: Jpn J Infect Dis  68: 481-487. Link:
  13. Qiu N, Li R, Yu JG, Yang W, Zhang W, et al. (2014)  Comparison of Abbott and Da-an real-time PCR for quantitating serum HBV DNA: World J Gastroenterol 11762-11769. Link:
  14. Cheah PL, Koh CC, Nazarina AR, Teoh KH, Looi LM (2016)  Correlation of p16INK4a immunoexpression and human papillomavirus (HPV) detected by in-situ hybridization in cervical squamous neoplasia: Malays J Pathol  38 : 33-38. Link:
  15. Ko K, Kwon MJ, Lee EH, Woo HY, Park H (2016) Comparison of GeneFinder human papillomavirus (HPV) Liquid Beads Microarray PCR Kit and Hybrid Capture 2 Assay for Detection of HPV Infection:  J Clin Lab Anal 5 : 365-369. Link:
  16. Rooper LM, Gandhi M, Bishop JA, Westra WH (2016) RNA in-situ hybridization is a practical and effective method for determining HPV status of oropharyngeal squamous cell carcinoma including discordant cases that are p16 positive by immunohistochemistry but HPV negative by DNA in-situ hybridization: Oral Oncol 55: 11-16. Link: 
  17. Shaban NZ, Salem HH, Elsadany MA, Ali BA, Hassona EM, et al. (2016) Distribution of Glutathione S-Transferase Omega Gene Polymorphism with Different Stages of HBV Infection Including Hepatocellular Carcinoma in the Egyptian Population: Asian Pac J Cancer Prev 17 : 2145-2150. Link:
  18. Elsayed HM, Nabiel Y, Sheta T (2016) IL12 Gene Polymorphism in Association with Hepatocellular Carcinoma in HCV-infected Egyptian Patients:  Immunol Invest 1 : 1-11. Link:
  19. De Baetselier I, Menten J, Cuylaerts V, Ahmed K, Deese J, et al. (2015) Prevalence and incidence estimation of HSV-2 by two IgG ELISA methods among South African women at high risk of HIV: PloS one  10 : e0120207. Link:              
  20. Huang XY, Huang T, Li F, Liu C, Zhang L, et al. (2015) HBV infection in donors with different HBsAg ELISA results by two kits: Chinese iournal of experimental and clinical virology  29 : 236-237. Link:
© 2017 Yulu G. This is an open-gjcvcess article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Help ?